Epidemiological models have played an influential role in governments’ responses to the COVID-19 pandemic. Yale SOM’s Edieal Pinker takes a look back at one of the most influential models and argues that such rigorous efforts at understanding the likely course of the disease, while imperfect, are critical to good decision making.
Debilitated by COVID-19, airlines are preparing to cut more than 30,000 jobs as soon as next month. We asked Prof. Kevin Williams to explain some of the economics of air travel and how the industry can survive in an age of stay-at-home orders.
Bikram Sohal ’97, who began the year leading the Indian office of a global ad-tech company, describes the impact of COVID-19 in India, a country with deep ties to the global economy but where much of the economy is still informal.
A year into his term as governor of Connecticut, Ned Lamont ’80 found himself with a new agenda: responding to the state’s outbreak of COVID-19, one of the first and most severe in the country. We talked with him about the partnerships he formed to bring down Connecticut’s infection rate and the risks that lie ahead.
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Prof. Andrew Metrick, director of the Yale Program on Financial Stability, says that fighting a crisis is different from economic policymaking in normal times; governments need to be exceptionally generous and not get bogged down in stringent processes that keep money from getting to those in need.